Gluten Contamination in Naturally or Labeled Gluten-Free Products Marketed in Italy
- PMID: 28178205
- PMCID: PMC5331546
- DOI: 10.3390/nu9020115
Gluten Contamination in Naturally or Labeled Gluten-Free Products Marketed in Italy
Abstract
Background: A strict and lifelong gluten-free diet is the only treatment of celiac disease. Gluten contamination has been frequently reported in nominally gluten-free products. The aim of this study was to test the level of gluten contamination in gluten-free products currently available in the Italian market.
Method: A total of 200 commercially available gluten-free products (including both naturally and certified gluten-free products) were randomly collected from different Italian supermarkets. The gluten content was determined by the R5 ELISA Kit approved by EU regulations.
Results: Gluten level was lower than 10 part per million (ppm) in 173 products (86.5%), between 10 and 20 ppm in 9 (4.5%), and higher than 20 ppm in 18 (9%), respectively. In contaminated foodstuff (gluten > 20 ppm) the amount of gluten was almost exclusively in the range of a very low gluten content. Contaminated products most commonly belonged to oats-, buckwheat-, and lentils-based items. Certified and higher cost gluten-free products were less commonly contaminated by gluten.
Conclusion: Gluten contamination in either naturally or labeled gluten-free products marketed in Italy is nowadays uncommon and usually mild on a quantitative basis. A program of systematic sampling of gluten-free food is needed to promptly disclose at-risk products.
Keywords: R5 ELISA; buckwheat; celiac disease; gluten-free products; lentils; naturally gluten-free; oats.
Conflict of interest statement
Carlo Catassi has received consultancy funds from Schär. Other authors declare no conflict of interest.
Figures
References
-
- Lionetti E., Castellaneta S., Francavilla R., Pulvirenti A., Tonutti E., Amarri S., Barbato M., Barbera C., Barera G., Bellantoni A., et al. Introduction of gluten, HLA status, and the risk of celiac disease in children. N. Engl. J. Med. 2014;371:1295–1303. doi: 10.1056/NEJMoa1400697. - DOI - PubMed
-
- Catassi C., Fabiani E., Iacono G., D’Agate C., Francavilla R., Biagi F., Volta U., Accomando S., Picarelli A., De Vitis I., et al. A prospective, double-blind, placebo-controlled trial to establish a safe gluten threshold for patients with celiac disease. Am. J. Clin. Nutr. 2007;85:160–166. - PubMed
-
- Gibert A., Kruizinga A.G., Neuhold S., Houben G.F., Canela M.A., Fasano A., Catassi C. Might gluten traces in wheat substitutes pose a risk in patients with celiac disease? A population-based probabilistic approach to risk estimation. Am. J. Clin. Nutr. 2013;97:109–116. doi: 10.3945/ajcn.112.047985. - DOI - PubMed
-
- Codex Alimentarius Commission . Foods for Special Dietary Use for Persons Intolerant to Gluten Codex STAN 118-1979. Codex Alimentarius Commission; Rome, Italy: 2008.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
